St. Jude Daig Division Splits To Emphasize Vascular Closure, AF Devices
This article was originally published in The Gray Sheet
Executive Summary
Newly appointed president of St. Jude Medical's cardiology division Paul Buckman will work to retain AngioSeal's number-one position in the U.S. vascular closure device market as newcomer Abbott Labs tries to gain ground